All data are based on the daily closing price as of August 12, 2025
u
Universal Vision Biotechnology
3218.TWO
6.89 USD
0.03
+0.44%
Overview
Last close
6.89 usd
Market cap
583.38M usd
52 week high
9.36 usd
52 week low
4.85 usd
Target price
7.09 usd
Valuation
P/E
15.6203
Forward P/E
N/A
Price/Sales
4.0875
Price/Book Value
5.1749
Enterprise Value
532.69M usd
EV/Revenue
3.7323
EV/EBITDA
8.189
Key financials
Revenue TTM
142.73M usd
Gross Profit TTM
84.66M usd
EBITDA TTM
59.04M usd
Earnings per Share
0.44 usd
Dividend
0.25 usd
Total assets
186.94M usd
Net debt
N/A usd
About
Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses for myopia, hyperopia, presbyopia, and astigmatism. Furthermore, it offers eye plastic and micro cosmetic surgery; and aesthetic medicine consulting services, and provides nutritional supplements for eye protection. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan.